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Definition of the T-lymphocyte responses to dengue viruses should aid in the development of safe and effective
vaccines and help to explain the pathophysiology of dengue hemorrhagic fever and dengue shock syndrome. In
this study, we demonstrated that dengue virus-specific T lymphocytes were detected in spleen cells from dengue
virus-immune mice using an in vitro proliferation assay. Following immunization with a single dose of
infectious dengue virus, murine lymphocytes showed increased proliferation when incubated in the presence of
viral antigens of the same serotype but not in the presence of control antigens. Depletion experiments with
antibody and complement showed that the population of responding cells expressed the Thyl+ L3T4+ Lyt2-
phenotype. This indicates that the predominant proliferating cells are T lymphocytes of the helper-inducer
phenotype. Dengue virus-specific memory lymphocyte responses were detectable for at least 22 weeks after
immunization. The response to primary infection was primarily serotype specific, with some serotype
cross-reactivity present at a low level. We demonstrated that lymphocytes from mice immunized with dengue
4 virus proliferate in response to a combination of dengue 4 virus C, pre-M, E, NS1, and NS2a proteins
expressed in Sf9 cells with a recombinant baculovirus, and, to a lesser extent, to the dengue 4 virus E protein
alone.
Infection with dengue viruses continues to present a major
public health problem (7). The World Health Organization
has targeted dengue viruses for intensive work toward
vaccine development (2). A major concern has been to
prevent the occurrence of severe complications, such as
hemorrhage or shock, which have been reported to be
related to the presence of preexisting immunity to a heter-
ologous dengue virus serotype (3, 8, 20). This unusual
phenomenon has been speculated to be due to antibody-
dependent enhancement of infection of Fc receptor-bearing
cells such as monocytes based on in vitro studies (9). A role
for T cells has also been postulated, as, for example, in the
immune elimination of infected monocytes (6) and in elabo-
ration of gamma interferon, which can further augment the
antibody-dependent enhancement of infection (12).
There have been few studies of the T-lymphocyte re-
sponses to dengue virus. Previous studies with human lym-
phocytes in our laboratory have shown that a population of
CD4+ T cells from dengue virus-immune individuals can
proliferate after exposure to dengue virus antigens and that
these cells produce gamma interferon when stimulated (14).
However, these studies are limited by the long interval
between natural dengue virus infection and our testing and
by the inability to define previous natural exposure to
dengue virus and other flaviviruses that might alter the
immune responses. The study of cellular immune responses
to dengue virus in laboratory animals obviates some of these
concerns.
Defining the dengue virus epitopes that might be involved
in protection or immunopathological phenomena or both is
desirable for future vaccine development. We have begun to
study the murine T-lymphocyte responses to dengue virus
and to viral proteins in order to identify such epitopes. We
report here the characterization of an in vitro proliferative
response to dengue virus antigens following immunization
* Corresponding author.
with live virus. Murine T-lymphocyte responses were pre-
dominantly serotype specific and, to a lesser extent, cross-
reactive after a single immunization with live virus. A
preparation containing recombinant dengue 4 virus C, pre-
M, E, NS1, and NS2a proteins or a similar preparation
containing dengue 4 virus E protein alone induced prolifer-
ative responses in T lymphocytes from dengue 4 virus-
immune mice.
MATERIALS AND METHODS
Mice. Male BALB/c mice were obtained from Charles
River Breeding Laboratories, Inc. (Wilmington, Mass.) and
were used between 4 and 8 weeks of age.
Viruses. Mouse-adapted dengue 1 virus (Hawaii strain),
dengue 2 virus (New Guinea C strain), dengue 3 virus (PR6
strain), and dengue 4 virus (814669 strain) were generously
provided as mouse brain homogenates by Jack McCown,
Walter Reed Army Institute of Research. These virus stocks
had titers of 107 to 108 PFU/ml in Vero cells by standard
techniques (13). Tissue culture-adapted dengue 2 virus (New
Guinea C strain) was kindly provided by W. Brandt, Walter
Reed Army Institute of Research. Dengue 3 virus (CH53489
strain) was kindly provided by B. Innis, Armed Forces
Research Institute of Medical Sciences. Viruses were prop-
agated in C6/36 cells as previously described (13). Culture
supernatants were collected 7 days after infection; they had
titers of 106 to 107 PFU/ml and were stored at -70°C.
Vero cell-derived dengue virus antigens. Dengue virus
antigens were produced as previously described (14). Vero
cells were grown to confluence and infected with dengue
viruses at an approximate multiplicity of infection of 1 PFU
per cell. When >50% cytopathic effect was noted (usually on
day 2 or 3 for dengue 2 virus and on day 3 or 4 for dengue 1,
3, or 4 virus), the cells were collected with a cell scraper,
washed with phosphate-buffered saline, and treated with
0.025% glutaraldehyde in phosphate-buffered saline for 15
min at 4°C. The cells were washed again and suspended in
2486
 at UNIV O
F M
ASS M
ED SCH on August 5, 2008 
jvi.asm.org
D
ow
nloaded from
 
MURINE T-LYMPHOCYTE RESPONSES TO DENGUE VIRUSES
RPMI medium and then sonicated with a sonic dismembra-
tor (Artek Systems Corp., Farmingdale, N.Y.) and centri-
fuged at 1,500 x g for 10 min. The supernatant was then
aliquoted and stored at -70°C. Similar preparations not
treated with glutaraldehyde had the following titers in Vero
cells: dengue 1 virus, 3.8 x 106 PFU/ml; dengue 2 virus, 1.7
x 107 PFU/ml, dengue 3 virus, 3.0 x 106 PFU/ml; and
dengue 4 virus, 2.8 x 106 PFU/ml. Control antigen was
prepared in identical fashion with uninfected Vero cells.
Recombinant baculovirus-derived dengue virus antigens.
Spodoptera fugiperda (Sf9) cells were infected with wild-
type and recombinant baculoviruses and prepared as previ-
ously described (23). Sf9 cells infected with a recombinant
baculovirus containing a 4.0-kilobase cDNA sequence of
dengue 4 virus 814669 strain have been shown to express
dengue 4 virus C, pre-M, E, NS1, and NS2a proteins (23). A
recombinant baculovirus containing a shorter cDNA se-
quence for the dengue 4 virus E protein was also used to
infect Sf9 cells.
Mouse immunization and preparation of spleen cells. Mice
were immunized intraperitoneally with one dose of 0.3 ml
(approximately 5 x 106 PFU) of mouse-adapted dengue
virus. Spleens were removed from mice 4 to 12 weeks after
immunization except as noted. Single-cell suspensions were
prepared by mincing and passing spleen tissue through
sterile gauze. Erythrocytes were lysed by brief exposure to
ACK lysing buffer (155 mM NH4CI, 10 mM KHCO3, 190
mM EDTA). Cells were then washed, and viable cells were
counted.
Measurement of lymphocyte proliferation. Proliferative re-
sponses to dengue virus antigens were tested by a modifica-
tion of the method of Chain et al. (4). Spleen cells (4 x 105)
were cultured with various dilutions of antigen in 0.1 ml of
RPMI 1640 medium supplemented with glutamine (2 mM),
100 U of penicillin per ml, 100 ,ug of streptomycin per ml,
2-mercaptoethanol (5 x 10-' M; Sigma Diagnostics, Ster-
ling, Va.), and 1% BALB/c mouse serum (Biotrol, Inc.,
Indianapolis, Ind.) in 96-well round-bottom plates (Costar,
Cambridge, Mass.). After 3 days of incubation at 37°C, the
culture medium was changed as follows. For most experi-
ments, 0.1 ml of RPMI 1640 supplemented with 5% fetal
bovine serum (Hyclone Laboratories, Inc., Logan, Utah)
was added to all wells. Cells were suspended by repeated
up-and-down pipetting, and 0.1 ml of the contents of each
well was transferred to a second 96-well round-bottom plate
containing 0.1 ml of RPMI 1640 with 5% fetal bovine serum
per well. Plates were incubated for two more days. Then the
cells were pulsed with 1.25 ,uCi of [3H]thymidine (Dupont,
NEN Research Products, Boston, Mass.) per well for 6 h.
Cells were harvested onto glass filter paper with a semiau-
tomatic cell harvester (Skatron, Inc., Sterling, Va.), and [3H]
thymidine incorporation was measured in a liquid scintilla-
tion counter (Packard Instrument Co., Inc., Sterling, Va.).
The stimulation index was calculated by dividing the mean
counts per minute (cpm) of triplicate wells incubated with
viral antigen by the mean cpm of triplicate wells incubated
with control antigen. A stimulation index of 2 or greater was
considered significant.
Antibody and complement depletion of responding cells.
Anti-Thyl.2 antibody obtained from Dupont, NEN Re-
search products, was used at a concentration of 1:100.
Anti-L3T4 and anti-Lyt2 antibodies obtained from Becton
Dickinson and Co. (Mountview, Calif.) and goat anti-mouse
immunoglobulin G obtained from Organon Teknika (Mal-
vern, Pa.) were used at a concentration of 1:20. In separate
experiments, nonimmune spleen cell preparations were
treated with the indicated antibody concentrations and com-
plement. When examined by direct fluorescence micros-
copy, less than 4% of the corresponding cell populations
remained.
In the depletion experiments, on day 3 of culture, 0.1 ml of
RPMI 1640 supplemented with 10% fetal bovine serum was
added to each well. After two more days, cells were col-
lected by aspirating wells. The cells were washed with RPMI
1640 without serum, and 5 x 106 cells were suspended in 1.0
ml of the indicated antibody and incubated for 1 h at 4°C.
The cells were washed again with RPMI 1640 and then
suspended in 1.0 ml of rabbit complement (Low-Tox-M;
Cedarlane Laboratories, Hornby, Ontario, Canada) diluted
1:10 in RPMI 1640 for 1 h at 37°C. The cells were washed and
suspended in 2.5 ml of RPMI 1640 supplemented with 10%
fetal bovine serum. Equal volumes (0.2 ml) from each
treated sample were added to 6 wells of a 96-well round-
bottom plate, and 1.25 ,uCi of [3H]thymidine was added to
each well. After 18 h of incubation, cells were harvested
onto glass filter paper and [3H]thymidine incorporation was
measured as described above.
Statistics. Statistical comparison of [3H]thymidine incor-
poration between groups was done by Student's t test (one
tailed), and P <0.05 was used as the criterion for statistical
significance.
RESULTS
Stimulation of lymphocyte proliferation by homologous
dengue virus antigens. Groups of mice were immunized with
one dose of live virus of a single dengue virus serotype, and
the spleen cells were incubated with antigens of the homol-
ogous dengue virus serotype. Spleen cells from mice immu-
nized with any of the serotypes proliferated significantly
when incubated in the presence of viral antigen (Fig. la to d).
The response was dengue virus specific, as demonstrated by
the failure of the control Vero cell antigen to stimulate as
high a response. Spleen cells of nonimmune mice did not
show a specific response to the dengue virus or control
antigens (Fig. 1). The response depended on the concentra-
tion of antigen present in the culture medium, but significant
stimulation was seen at antigen dilutions of 1:200 or higher.
To determine the phenotypes of the proliferating cells, we
treated the 5-day-cultured spleen cells with antibody and
complement prior to pulsing with [3H]thymidine. The in-
crease in [3H]thymidine incorporation was eliminated by
treatment with anti-Thyl antibody and complement (Fig. 2),
demonstrating that the responder cell was a T lymphocyte.
Treatment with anti-L3T4 and complement but not anti-Lyt2
and complement also reduced the level of [3H]thymidine
incorporation. This indicates that T lymphocytes of the
helper-inducer phenotype made up the predominant re-
sponding population.
Mice were tested at various times after immunization to
determine the duration of the immune response. Dengue
virus-specific T-lymphocyte responses were detected as
early as 2 weeks after immunization (Fig. 3). This response
remained for at least 10 weeks. Significant stimulation was
still detected 22 weeks after immunization. In separate
experiments, dengue virus-specific lymphocyte proliferation
(stimulation index, 2.2 to 2.8) was detected over 1 year after
immunization (data not shown).
Serotype specificity of dengue virus-specific lymphocyte
proliferation. To determine the specificity of the proliferative
responses, spleen cells from mice immunized with a single
dengue virus serotype were incubated with antigens of all
VOL. 63, 1989 2487
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FIG. 1. Proliferative responses to homologous dengue virus antigens. Mice were immunized with one of the four dengue virus serotypes,
and spleen cells were later tested with antigens from the same serotype. Symbols: *, U, responses to viral antigens; 0, 0, responses to
control antigens. 0, 0, mice immunized with the indicated virus; U, 0, unimmunized mice.
four dengue virus serotypes and yellow fever virus. Follow-
ing immunization with a single serotype of dengue virus,
lymphocyte proliferation was greatest in response to incu-
bation with the homologous dengue virus serotype (Table 1).
There was some response to the heterologous dengue virus
serotypes and to yellow fever virus. Using our criterion of a
stimulation index of >2.0, we noted significant proliferative
responses with dengue 1 virus-immune spleen cells incu-
bated with dengue 3 virus antigen (experiment 1), with
dengue 2 virus-immune spleen cells incubated with dengue 3
virus and yellow fever virus antigens (experiment 1), and
with dengue 4 virus-immune cells incubated with dengue 2
virus antigen (experiment 2).
Stimulation of lymphocyte proliferation by baculovirus-
dengue virus recombinants. Spleen cells from mice immu-
nized with a single dose of live dengue 4 virus were also
tested for the ability to proliferate after incubation with
dengue virus antigens expressed by using a recombinant
baculovirus vector. Dengue 4 virus-immune spleen cells
were stimulated by a lysate of Sf9 cells infected with a
Treatment
none .>
.....
C' only Z ZI3
Anti-Thyl.2 + C'
Anti-L3T4 + C'
Anti-Lyt2 + C'
Anti-lgG + C'
0 1 0 20 30 40 50 60
[3 H]-Thymidine incorporation (1 0 3 CPM)
FIG. 2. Effect of depletion with antibody and complement (c') on
the proliferative response. Mice were immunized with dengue 2
virus, and 4 weeks later the spleen cells were harvested and
incubated with a 1:200 dilution of dengue 2 virus antigen as
described in Materials and Methods. Depletions were carried out at
the end of the 5-day incubation period. The mean cpm of
[3H]thymidine incorporation of cells incubated with control antigen
in this experiment were 17,909 with no treatment and 13,986 after
treatment with complement alone.
recombinant baculovirus expressing dengue 4 virus C, pre-
M, E, NS1, and NS2a proteins (Fig. 4a). The T-cell re-
sponses were specific for the dengue 4 virus proteins ex-
pressed, e.g., the stimulation index was 7.8 (at an antigen
dilution of 1:2,560) compared with the control preparation of
wild-type baculovirus-infected Sf9 cells. Spleen cells from
nonimmune mice did not show a dengue virus-specific
response (Fig. 4a).
We also detected dengue virus-specific stimulation by
dengue 4 virus E protein alone using a recombinant baculo-
virus containing a shorter dengue 4 virus genome sequence
(Fig. 4b). The response to the E protein-containing prepara-
tion was lower than the response to the preparation contain-
ing multiple dengue 4 virus proteins. Nonimmune mice did
not show a response to this subunit preparation (data not
shown).
DISCUSSION
We demonstrated the presence of dengue virus-specific
memory T lymphocytes following immunization with a sin-
gle dose of live dengue virus. We used a modification of the
usual lymphocyte proliferation assay to provide a superior
signal-to-noise ratio by diminishing the level of nonspecific
0)
CZ70
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8 *0
0
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0
4-
2-
o Control
0 2 4 6 8 10 12 14 16 18 20 22 24
Weeks After Infection
FIG. 3. Persistence of memory T-lymphocyte responses to den-
gue virus after immunization. Individual mice were immunized with
dengue 2 virus at various times before testing. Spleen cells from all
mice were stimulated in vitro in the same assay. Dengue 2 virus and
control antigens (ag) were added to wells at 1:2,000 dilution.
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TABLE 1. Dengue virus serotype specificity of
lymphocyte proliferation
Response to viral antigen"
Expt Immunizing
no. dengue virus Dengue Dengue Dengue Dengue Yellow
1 2 3 4 fever
1 1 7.3 1.9 2.1 1.3
2 1.7 10.6 2.5 2.4
None 1.5 1.3 0.9 1.2
2 2 0.9 3.9 0.8 0.9 0.8
3 1.7 1.9 4.7 1.4 1.3
4 1.0 4.2 1.6 7.7 1.2
None 0.5 1.2 1.3 1.1 1.5
a Values expressed as stimulation index calculated as cpm of cells incu-
bated with viral antigen divided by cpm of cells incubated with control
antigen. Values representing the responses to homologous viral antigens are
underlined. Antigens were used as 1:200 dilution in experiment 1 and at
1:2,000 dilution in experiment 2. [3H]thymidine incorporation (cpm) of spleen
cells incubated with the control antigen preparation was as follows: experi-
ment 1, dengue 1 virus immune, 2,466; dengue 2 virus immune, 2,530;
nonimmune, 2,198; experiment 2, dengue 2 virus immune, 2,545; dengue 3
virus immune, 2,174; dengue 4 virus immune, 1,117; nonimmune, 231.
proliferation. Preliminary studies had shown that the method
used in these experiments was optimal for revealing dengue
virus-specific lymphoproliferative responses (A. L. Roth-
man, I. Kurane, and F. A. Ennis, manuscript in prepara-
tion).
We found the predominant proliferating population of
lymphocytes to be Thyl+ L3T4+ Lyt2- cells. However, we
cannot exclude the presence of some dengue virus-specific
Lyt2+ cytotoxic T cells. We used inactivated cell-associated
viral antigen as a stimulus, which may preferentially induce
the proliferation of L3T4+ cells (17). We have not yet
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characterized the functions of these stimulated cells. It has
been reported that cells of the helper-inducer phenotype are
involved in the delayed-type hypersensitivity response to
dengue 4 virus as measured by footpad swelling in cyclo-
phosphamide-treated mice (18). Alternatively, these cells
may provide help for antibody production or the generation
of cytotoxic T cells and produce gamma interferon, which
may increase the number of dengue virus-infected Fc recep-
tor-bearing cells and contribute to the immunopathological
processes which have been observed during secondary den-
gue virus infections (12, 14).
We observed that the memory T-cell responses after
primary infection with dengue viruses are directed predom-
inantly at serotype-specific determinants. We detected some
cross-reactive responses to other dengue virus serotypes and
to yellow fever virus, generally in those animals which
showed the highest levels of proliferation in response to the
homologous serotype. These cross-reactive responses were
generally only 25 to 30% as strong as the response to the
homologous serotype. We did detect a high level of cross-
reactive response to dengue 2 virus antigen in dengue 4
virus-immune mice, although there was no reciprocal level
of cross-reactivity in dengue 2 virus-immune mice. This
might be explained partly by the higher viral content in our
dengue 2 virus antigen or may indicate homology in the
T-cell epitopes of these two dengue virus serotypes. A
previous study on the delayed-type hypersensitivity re-
sponse to dengue 4 virus in mice had also noted a predom-
inantly serotype-specific response, with some cross-reac-
tivity to dengue 2 and dengue 1 viruses (19).
Our studies with human lymphocytes have shown a
greater degree of cross-reactivity of the proliferative re-
sponse among the four dengue virus serotypes (14). This
105 106 io2
1/Antigen Dilution
FIG. 4. Proliferative responses to recombinant baculovirus preparations. (a) Spleen cells from dengue 4 virus-immunized (O, 0, 0) and
control (EB, O, *) mice were incubated with lysates from uninfected Sf9 cells (O, i), wild-type baculovirus-infected Sf9 cells (0, OI), or
recombinant baculovirus-infected Sf9 cells (expressing dengue 4 virus C, pre-M, E, NS1, and NS2a proteins) (0, *). The standard deviations
of values with spleen cells from dengue virus-immune mice are the only ones shown, for clarity. (b) Spleen cells from dengue 4
virus-immunized mice were incubated with lysates from uninfected Sf9 cells (0), wild-type baculovirus-infected Sf9 cells (0), or recombinant
baculovirus-infected Sf9 cells expressing either multiple dengue 4 virus proteins (0) or only the dengue 4 virus E protein (A).
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difference may be due to the fact that some of the individuals
we studied had been immunized previously with yellow
fever virus vaccine or had experienced more than one
natural flavivirus infection, which might have augmented
their cross-reactive T-lymphocyte clones.
Uren et al. (22) have reported cross-reactive proliferation
of murine L3T4+ T-cell clones among the Kunjin, West Nile,
and Murray Valley encephalitis flaviviruses. Several differ-
ences between that study and ours may explain the differ-
ence in findings. They used C57BL/6J (H-2b) mice and
stimulated spleen cells with UV-irradiated mouse brain
homogenates. Furthermore, they report results for T-cell
clones isolated after repeated in vitro restimulation with
antigen. Such manipulation might favor the growth of a
cross-reactive T-cell population. We are establishing T-cell
clones to further define the specificity of murine lympho-
cytes to dengue virus.
It should be noted that our finding of relative serotype
specificity of the lymphocyte response is confined to the
L3T4+ Lyt2- population that responded in our system. It is
plausible that an L3T4- Lyt2+ lymphocyte population might
respond to serotype-cross-reactive epitopes and might be
capable of lysing infected monocytes during secondary den-
gue virus infections. Another possibility is that glutaralde-
hyde fixation, employed in preparation of our dengue virus
antigen preparation, selectively altered cross-reactive
epitopes. However, we have not seen a higher level of
cross-reactivity in experiments with infectious cell-free virus
preparations (A. L. Rothman, I. Kurane, and F. A. Ennis,
unpublished observations). It is also conceivable that virus
strains associated with a higher incidence of hemorrhagic
fever or shock might be more cross-reactive. Morens and
Halstead (16) reported that strains of dengue 2 virus associ-
ated with more severe disease were more likely to demon-
strate in vitro enhancement of infection by a panel of
monoclonal antibodies to dengue 4 virus.
We also showed that immune spleen cells proliferate in
response to dengue 4 virus proteins expressed by a baculo-
virus vector. This preparation, which contained dengue 4
virus C, pre-M, E, NS1, and NS2a proteins, was protective
to mice against subsequent intracerebral challenge with
dengue 4 virus (23). Using a dengue 4 virus subunit prepa-
ration expressed by the recombinant baculovirus vector, we
demonstrated that dengue 4 virus-immune lymphocytes rec-
ognize the E protein of dengue 4 virus. Previous studies in
mice have shown that monoclonal antibodies directed
against the E glycoprotein of dengue 2 virus protected
recipient mice against later intracerebral challenge with the
same virus (11). Antibody directed against shared epitopes
on the E glycoprotein protected against challenge with
yellow fever virus as well (1). However, anti-E antibodies
can enhance infection of Fc receptor-bearing cells in vitro at
higher dilutions (10), and immunization with dengue 2 virus
E protein expressed by a recombinant vaccinia virus failed
to protect monkeys against virus challenge (5). Therefore,
the E protein might not be ideal for vaccine development.
Schlesinger et al. (21) have demonstrated that immuniza-
tion of mice with the NS1 glycoprotein of dengue 2 virus
induced protection against later intracerebral challenge. Im-
munization did not result in the development of antibodies to
structural proteins, making it unlikely that enhancement of
subsequent infection would occur. Although the NS1 protein
is highly conserved among flaviviruses (15) and the antibody
response to NS1 immunization was cross-reactive in com-
plement fixation assays, cross-protection against a subse-
quent challenge with dengue 1 virus was not seen (21). We
postulate that a failure to stimulate cross-reactive memory T
lymphocytes may explain this shortcoming. We will test this
possibility using purified or recombinant NS1 protein in
experiments employing the same approaches reported here.
Future studies will be directed toward examining the
effector functions of the memory T-lymphocyte population,
including a search for their possible cytotoxic role. In
addition, other recombinant viruses expressing structural
and nonstructural dengue virus proteins will be used to
identify the location of the predominant T-cell epitopes
which may be involved in protective or immunopathological
functions.
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